menu
    • menu

    Company profile for Cullinan Therapeutics

    NEW Drugs in Dev.: 7
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Cullinan Therapeutics, our approach to drug discovery and development is modality-agnostic and targeted, aiming to create molecules that could significantly improve patients' lives. Formerly known as Cullinan Oncology, our company was established in 2016 and is based in the vibrant science and technology hub of Cambridge, Massachusetts. With a dedicated team boasting diverse backgrounds and expertise, we foster a collaborat...
    At Cullinan Therapeutics, our approach to drug discovery and development is modality-agnostic and targeted, aiming to create molecules that could significantly improve patients' lives. Formerly known as Cullinan Oncology, our company was established in 2016 and is based in the vibrant science and technology hub of Cambridge, Massachusetts. With a dedicated team boasting diverse backgrounds and expertise, we foster a collaborative culture deeply rooted in our commitment to following the science. This collective effort drives us to explore new solutions and push the boundaries of innovation in healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cullinan TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cullinantherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cullinantx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CullinanTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cullinan Pharma Updates On Corporate Progress, 2026 Milestones
    Cullinan Pharma Updates On Corporate Progress, 2026 Milestones

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215212/0/en/Cullinan-Therapeutics-Provides-Corporate-Update-and-Highlights-Anticipated-2026-Milestones.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Cullinan Presents CLN-049 AML Data at 67th ASH Meeting
    Cullinan Presents CLN-049 AML Data at 67th ASH Meeting

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201707/0/en/Cullinan-Therapeutics-Showcases-Compelling-Clinical-Data-in-AML-for-CLN-049-Novel-FLT3xCD3-T-Cell-Engager-in-Oral-Presentation-at-the-67th-ASH-Meeting.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Cullinan Receives FDA Fast Track Designation for CLN-049
    Cullinan Receives FDA Fast Track Designation for CLN-049

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196843/0/en/Cullinan-Therapeutics-Receives-FDA-Fast-Track-Designation-for-CLN-049-a-Novel-FLT3xCD3-T-Cell-Engager-in-Relapsed-Refractory-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-taiho-pharmaceutical-and-cullinan-therapeutics-initiate-rolling-submission-of-new-drug-application-to-us-food-and-drug-administration-for-zipalertinib-for-treatment-of-locally-advanced-or-metastatic-non-small-cel-302621302.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Cullinan Therapeutics To Present At Investor Conferences
    Cullinan Therapeutics To Present At Investor Conferences

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184394/0/en/Cullinan-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-and-Host-Analyst-and-Investor-Event-at-2025-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Cullinan Therapeutics Presents Strong Clinical Data On CLN-049
    Cullinan Therapeutics Presents Strong Clinical Data On CLN-049

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179412/0/en/Cullinan-Therapeutics-to-Showcase-New-Data-Demonstrating-Compelling-Clinical-Activity-for-CLN-049-a-Novel-FLT3xCD3-T-Cell-Engager-in-AML-Patients-in-an-Oral-Presentation-at-the-67t.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search